New Releases from NCBI BookshelfOlopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Ryaltris): Indication: For the symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms in adults, adolescents, and children aged 6 years and older: Reimbursement Recommendation [Internet].​Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Ryaltris): Indication: For the symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms in adults, adolescents, and children aged 6 years and older: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Ryaltris should not be reimbursed by public drug plans for the symptomatic treatment of moderate-to-severe seasonal allergic rhinitis and associated ocular symptoms in adults, adolescents, and children aged 6 years and older.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top